1
1TL;DR: Marken (part of UPS Healthcare) just combined all their superpowers into one seamless network across Asia-Pacific. From clinical trials to commercial drug delivery, medical devices to patient-centered logistics—it’s now one team, one network, one connected journey.
Imagine you’re a pharmaceutical company developing a new medicine. You need to:
Before: You’d juggle multiple vendors, contracts, and tracking systems. Headache city.
Now: Marken + UPS Healthcare = one integrated partner handling everything across APAC (Asia-Pacific). Faster. Simpler. More visible. More reliable.
IMPORTANT POINT
This isn’t just a partnership—it’s a full integration. Marken’s clinical/patient expertise + UPS’s global scale/speed = a single, GMP/GDP-compliant network built for the entire lifecycle of a therapy: from first-in-human trial to commercial launch and beyond.
| Pillar | What It Covers | Why It’s Cool |
|---|---|---|
| Pharma | Clinical & commercial drug storage, advanced therapy logistics, cold chain—all under one roof | No more handoffs between "clinical vendor" and "commercial vendor" |
| Medical Devices | Connected device logistics, deployment, lifecycle support, technical services, reverse logistics | Devices get the same precision handling as life-saving drugs |
| Network | UPS Freight, Express & Gold services + Marken specialty courier, depots, packaging, patient/site capabilities | One tracking system, one point of contact, one bill |
“Customers need supply chains as connected and agile as the therapies they support. Our integrated end-to-end solution gives them one trusted partner from clinical to commercial, with greater speed, visibility and confidence. We are expanding our capabilities in the region with our three state-of-the-art GMP and GDP-compliant facilities in Singapore, fully equipped to store and distribute commercial drugs in the most optimized way. One UPS, but so much faster.”
— Ariette van Strien, President, Marken“Healthcare companies are rethinking how they design and manage supply chains for the next wave of innovation. At Marken, we have a regional network built for this complexity and pace, allowing us to move faster, coordinate more effectively and tailor solutions across APAC, while maintaining the quality and reliability our customers expect.”
— Poh Meng, Vice President, APAC
| Before | After (Marken + UPS Healthcare) |
|---|---|
| Multiple vendors | One integrated partner |
| Clinical ≠ Commercial systems | Single quality & tech stack |
| Limited APAC footprint | 300K+ sq ft, 3 GMP hubs, 40+ countries |
| Reactive problem-solving | Proactive, end-to-end visibility |
| Slow tech transfers | Seamless trial-to-launch flow |
Result: Faster time-to-market. Lower risk. Happier patients.
GMP = Good Manufacturing Practice (how drugs are made/stored). GDP = Good Distribution Practice (how they’re moved). Both are global gold standards—think of them as the "FDA seal of approval" for logistics. Marken’s Singapore facilities have both.
Not at all! The network is scalable. A 10-site Phase II trial gets the same precision as a 40-country commercial launch. You pay for what you use.
It’s designed around the patient: temperature-controlled direct-to-home delivery, scheduled time windows, returns kits for used devices, real-time alerts to caregivers. Think UberEats meets clinical trial.
Yes! Advanced therapy logistics is explicitly called out. That means ultra-cold (-80°C to -196°C), chain-of-identity, chain-of-custody, just-in-time delivery to infusion centers—all supported.
Email expert@marken.com or contact your Marken rep. They’ll map your current supply chain, identify gaps, and co-design a solution—whether you’re in Phase I or prepping for multi-market launch.
Next Step: Reach out to expert@marken.com or your Marken representative to explore how the One Team. One Network. One Connected Journey. can accelerate your therapy from pipeline to patient.